BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2395844)

  • 1. [Combined use of antitubercular drugs and metabolites of the tricarboxylic acid cycle in experimental tuberculosis].
    Sokirko TA; Maliuk VI; Klimenko MT; Suslov EI
    Probl Tuberk; 1990; (4):20-3. PubMed ID: 2395844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of experimental use of antitubercular preparations and various pathogenetic drugs on the immunological reactions of the body].
    Beliakova OI; Kharakter ZhZ; Sibirnaia RI; Snitinskaia OS
    Probl Tuberk; 1988; (4):65-8. PubMed ID: 3262223
    [No Abstract]   [Full Text] [Related]  

  • 3. [An experimental study of the chemotherapeutic efficacy of flurenizid, a new antitubercular pharmaceutical].
    Khomenko AG; Golyshevskaia VI; Maslova LI; Kalmykova GN; Uvarova OA
    Probl Tuberk; 1990; (6):3-7. PubMed ID: 2217100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of tuberculostatic agents and sodium succinate on the functional state of liver mitochondria in tuberculosis].
    Sokirko TA
    Vopr Med Khim; 1987; 33(4):83-6. PubMed ID: 3660747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Express intravenous administration of a complex of antituberculosis preparations in the treatment of destructive pulmonary tuberculosis].
    Bondarev IM; Zhigalina LI; Sokolova GB
    Probl Tuberk; 1977 Jul; (7):35-9. PubMed ID: 331307
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental study of therapeutic effect of various antibacterial drug combinations].
    Kozulitsyna TI; Uvarova OA; Golyshevskaia VI; El'shanskaia MP
    Probl Tuberk; 1980 Jul; (7):49-53. PubMed ID: 7413637
    [No Abstract]   [Full Text] [Related]  

  • 7. [Various indicators of the immunological response of the body after inclusion of pathogenetic agents in the chemotherapy of tuberculosis].
    Sibirnaia RI; Beliakova OI
    Probl Tuberk; 1984 Sep; (9):28-30. PubMed ID: 6334296
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chemotherapy in combination with the rapid intravenous administration of isoniazid in pulmonary tuberculosis].
    Zbants AN; Tsurkan VP; Mustiatsé NA; Kurochkin SIa; Ustiian AI
    Probl Tuberk; 1982 Dec; (12):45-8. PubMed ID: 7156122
    [No Abstract]   [Full Text] [Related]  

  • 9. Liposome-based antitubercular drug therapy in a guinea pig model of tuberculosis.
    Pandey R; Sharma S; Khuller GK
    Int J Antimicrob Agents; 2004 Apr; 23(4):414-5. PubMed ID: 15081096
    [No Abstract]   [Full Text] [Related]  

  • 10. [Isoniazid pharmacokinetics in the combined chemotherapy of tuberculosis].
    Sokolova GB; Vilenskaia RN; Ivleva AIa; Galenko NN; Ziia AV
    Probl Tuberk; 1981 Oct; (10):24-8. PubMed ID: 7312844
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunological reactivity during the pathogenetic treatment of experimental tuberculosis].
    Sibirnaia RI; Snitinskaia OS
    Vrach Delo; 1990 Feb; (2):77-9. PubMed ID: 2339563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The morphological reactions in the lungs during the chemotherapy of experimental tuberculosis].
    Erokhin VV
    Probl Tuberk; 2000; (5):15-9. PubMed ID: 11077845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of isoniazid administration on pulmonary tuberculous patients with isoniazid-resistant strain.
    Oka S; Motomiya M; Sato H; Fujimoto M
    Sci Rep Res Inst Tohoku Univ Med; 1967 Nov; 14(3):177-80. PubMed ID: 4978373
    [No Abstract]   [Full Text] [Related]  

  • 14. [Short-term intensive therapy of destructive pulmonary tuberculosis].
    Bondarev IM; Zhigalina LI; Kunichan AD
    Probl Tuberk; 1980 Dec; (12):57-9. PubMed ID: 7220536
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of patients with destructive pulmonary tuberculosis using intramuscular isoniazid administration].
    Panasiuk AV; Il'nitskiĭ IG; Kunichkina SA; Azarenko II; Lola AT
    Vrach Delo; 1988 Aug; (8):69-71. PubMed ID: 3206888
    [No Abstract]   [Full Text] [Related]  

  • 16. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML; Iuditskiĭ MV; Semenova OV
    Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of disseminated destructive pulmonary tuberculosis by intracavernous administration of antibacterial drugs].
    Guseĭnov GK; Gimbatov MM; Zhandulaev MM; Basirov MB
    Sov Med; 1990; (6):83-5. PubMed ID: 2396133
    [No Abstract]   [Full Text] [Related]  

  • 18. [New and future drugs in pulmonary tuberculosis].
    Grosset JH; Truffot-Pernot C; Lecoeur H
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():206-10. PubMed ID: 3174565
    [No Abstract]   [Full Text] [Related]  

  • 19. [Lymphotropic therapy in the combined treatment of pulmonary tuberculosis in children and adolescents].
    Lebedeva LV; Olianishin VN; Kadnikova ON
    Probl Tuberk; 1989; (5):26-8. PubMed ID: 2787506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Controversy over tuberculosis therapy in HIV infected patients. Isoniazide therapy--brief chemotherapy].
    Arnheim K
    Fortschr Med; 1995 Dec; 113(35-36):14-5. PubMed ID: 8582689
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.